Robuta

https://pubmed.ncbi.nlm.nih.gov/25938892/
A novel immunoconjugate (L-DOS47) was developed and characterized as a therapeutic agent for tumors expressing CEACAM6. The single domain antibody AFAIKL2,...
single domain antibodyproductioncharacterizationcamelidurease
https://www.ncbi.nlm.nih.gov/Structure/pdb/7R98
Nanobody B6Nucleoprotein
sars covstructuren
https://pubmed.ncbi.nlm.nih.gov/24100387/?dopt=Abstract
The efficacy of immunotherapy based on natural killer (NK) cells is hampered by intrinsic non-specific cytotoxicity and insufficient activation of NK cells....
retargetingnkantimelanomaactivity